[1]
|
NUCLEOTIDE SEQUENCE [MRNA].
DOI=10.1093/nar/14.13.5275; PubMed=3737401 [NCBI, ExPASy, EBI, Israel, Japan]
Erba H.P.,
Gunning P.,
Kedes L.;
"Nucleotide sequence of the human gamma cytoskeletal actin mRNA: anomalous evolution of vertebrate non-muscle actin genes.";
Nucleic Acids Res. 14:5275-5294(1986).
|
[2]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=2837653 [NCBI, ExPASy, EBI, Israel, Japan]
Erba H.P.,
Eddy R.,
Shows T.,
Kedes L.,
Gunning P.;
"Structure, chromosome location, and expression of the human gamma-actin gene: differential evolution, location, and expression of the cytoskeletal beta- and gamma-actin genes.";
Mol. Cell. Biol. 8:1775-1789(1988).
|
[3]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
DOI=10.1038/ng1285; PubMed=14702039 [NCBI, ExPASy, EBI, Israel, Japan]
Ota T.,
Suzuki Y.,
Nishikawa T.,
Otsuki T.,
Sugiyama T.,
Irie R.,
Wakamatsu A.,
Hayashi K.,
Sato H.,
Nagai K.,
Kimura K.,
Makita H.,
Sekine M.,
Obayashi M.,
Nishi T.,
Shibahara T.,
Tanaka T.,
Ishii S.,
Yamamoto J., ![]()
Saito K.,
Kawai Y.,
Isono Y.,
Nakamura Y.,
Nagahari K.,
Murakami K.,
Yasuda T.,
Iwayanagi T.,
Wagatsuma M.,
Shiratori A.,
Sudo H.,
Hosoiri T.,
Kaku Y.,
Kodaira H.,
Kondo H.,
Sugawara M.,
Takahashi M.,
Kanda K.,
Yokoi T.,
Furuya T.,
Kikkawa E.,
Omura Y.,
Abe K.,
Kamihara K.,
Katsuta N.,
Sato K.,
Tanikawa M.,
Yamazaki M.,
Ninomiya K.,
Ishibashi T.,
Yamashita H.,
Murakawa K.,
Fujimori K.,
Tanai H.,
Kimata M.,
Watanabe M.,
Hiraoka S.,
Chiba Y.,
Ishida S.,
Ono Y.,
Takiguchi S.,
Watanabe S.,
Yosida M.,
Hotuta T.,
Kusano J.,
Kanehori K.,
Takahashi-Fujii A.,
Hara H.,
Tanase T.-O.,
Nomura Y.,
Togiya S.,
Komai F.,
Hara R.,
Takeuchi K.,
Arita M.,
Imose N.,
Musashino K.,
Yuuki H.,
Oshima A.,
Sasaki N.,
Aotsuka S.,
Yoshikawa Y.,
Matsunawa H.,
Ichihara T.,
Shiohata N.,
Sano S.,
Moriya S.,
Momiyama H.,
Satoh N.,
Takami S.,
Terashima Y.,
Suzuki O.,
Nakagawa S.,
Senoh A.,
Mizoguchi H.,
Goto Y.,
Shimizu F.,
Wakebe H.,
Hishigaki H.,
Watanabe T.,
Sugiyama A.,
Takemoto M.,
Kawakami B.,
Yamazaki M.,
Watanabe K.,
Kumagai A.,
Itakura S.,
Fukuzumi Y.,
Fujimori Y.,
Komiyama M.,
Tashiro H.,
Tanigami A.,
Fujiwara T.,
Ono T.,
Yamada K.,
Fujii Y.,
Ozaki K.,
Hirao M.,
Ohmori Y.,
Kawabata A.,
Hikiji T.,
Kobatake N.,
Inagaki H.,
Ikema Y.,
Okamoto S.,
Okitani R.,
Kawakami T.,
Noguchi S.,
Itoh T.,
Shigeta K.,
Senba T.,
Matsumura K.,
Nakajima Y.,
Mizuno T.,
Morinaga M.,
Sasaki M.,
Togashi T.,
Oyama M.,
Hata H.,
Watanabe M.,
Komatsu T.,
Mizushima-Sugano J.,
Satoh T.,
Shirai Y.,
Takahashi Y.,
Nakagawa K.,
Okumura K.,
Nagase T.,
Nomura N.,
Kikuchi H.,
Masuho Y.,
Yamashita R.,
Nakai K.,
Yada T.,
Nakamura Y.,
Ohara O.,
Isogai T.,
Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human cDNAs.";
Nat. Genet. 36:40-45(2004).
|
[4]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Kalnine N.,
Chen X.,
Rolfs A.,
Halleck A.,
Hines L.,
Eisenstein S.,
Koundinya M.,
Raphael J.,
Moreira D.,
Kelley T.,
LaBaer J.,
Lin Y.,
Phelan M.,
Farmer A.;
"Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
|
[5]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=B-cell, Eye, Lung, Ovary, Placenta, Skin, and Uterus;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[6]
|
PROTEIN SEQUENCE OF 2-28.
TISSUE=Platelet;
DOI=10.1038/nbt810; PubMed=12665801 [NCBI, ExPASy, EBI, Israel, Japan]
Gevaert K.,
Goethals M.,
Martens L.,
Van Damme J.,
Staes A.,
Thomas G.R.,
Vandekerckhove J.;
"Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.";
Nat. Biotechnol. 21:566-569(2003).
|
[7]
|
PROTEIN SEQUENCE OF 2-18; 29-37; 40-50; 85-113; 148-177; 184-191; 197-206; 239-254; 292-312 AND 316-326, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT GLU-2, AND MASS SPECTROMETRY.
TISSUE=B-cell lymphoma;
Bienvenut W.V.;
Submitted (JUN-2005) to UniProtKB.
|
[8]
|
PROTEIN SEQUENCE OF 2-113; 119-177; 184-191; 197-206; 239-254; 291-312; 316-326 AND 329-372, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT GLU-2, METHYLATION AT HIS-73, AND MASS SPECTROMETRY.
TISSUE=Ovarian carcinoma;
Bienvenut W.V.,
Lilla S.,
von Kriegsheim A.,
Lempens A.,
Kolch W.;
Submitted (DEC-2008) to UniProtKB.
|
[9]
|
PROTEIN SEQUENCE OF 29-39; 85-113; 239-254 AND 292-312, AND MASS SPECTROMETRY.
TISSUE=Brain, and Cajal-Retzius cell;
Lubec G.,
Afjehi-Sadat L.;
Submitted (MAR-2007) to UniProtKB.
|
[10]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 144-375.
DOI=10.1073/pnas.84.9.2575; PubMed=3472224 [NCBI, ExPASy, EBI, Israel, Japan]
Chou C.C.,
Davis R.C.,
Fuller M.L.,
Slovin J.P.,
Wong A.,
Wright J.,
Kania S.,
Shaked R.,
Gatti R.A.,
Salser W.A.;
"Gamma-actin: unusual mRNA 3'-untranslated sequence conservation and amino acid substitutions that may be cancer related.";
Proc. Natl. Acad. Sci. U.S.A. 84:2575-2579(1987).
|
[11]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-198 AND TYR-294, AND MASS SPECTROMETRY.
DOI=10.1016/j.cell.2007.11.025; PubMed=18083107 [NCBI, ExPASy, EBI, Israel, Japan]
Rikova K.,
Guo A.,
Zeng Q.,
Possemato A.,
Yu J.,
Haack H.,
Nardone J.,
Lee K.,
Reeves C.,
Li Y.,
Hu Y.,
Tan Z.,
Stokes M.,
Sullivan L.,
Mitchell J.,
Wetzel R.,
Macneill J.,
Ren J.M.,
Yuan J., ![]()
Bakalarski C.E.,
Villen J.,
Kornhauser J.M.,
Smith B.,
Li D.,
Zhou X.,
Gygi S.P.,
Gu T.-L.,
Polakiewicz R.D.,
Rush J.,
Comb M.J.;
"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.";
Cell 131:1190-1203(2007).
|
[12]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-318, AND MASS SPECTROMETRY.
TISSUE=Platelet;
DOI=10.1021/pr0704130; PubMed=18088087 [NCBI, ExPASy, EBI, Israel, Japan]
Zahedi R.P.,
Lewandrowski U.,
Wiesner J.,
Wortelkamp S.,
Moebius J.,
Schuetz C.,
Walter U.,
Gambaryan S.,
Sickmann A.;
"Phosphoproteome of resting human platelets.";
J. Proteome Res. 7:526-534(2008).
|
[13]
|
VARIANTS DFNA20 ILE-89; MET-118; LEU-264 AND ALA-332.
DOI=10.1086/379286; PubMed=13680526 [NCBI, ExPASy, EBI, Israel, Japan]
Zhu M.,
Yang T.,
Wei S.,
DeWan A.T.,
Morell R.J.,
Elfenbein J.L.,
Fisher R.A.,
Leal S.M.,
Smith R.J.H.,
Friderici K.H.;
"Mutations in the gamma-actin gene (ACTG1) are associated with dominant progressive deafness (DFNA20/26).";
Am. J. Hum. Genet. 73:1082-1091(2003).
|
[14]
|
VARIANT DFNA20 ILE-278.
DOI=10.1136/jmg.40.12.879; PubMed=14684684 [NCBI, ExPASy, EBI, Israel, Japan]
van Wijk E.,
Krieger E.,
Kemperman M.H.,
De Leenheer E.M.R.,
Huygen P.L.M.,
Cremers C.W.R.J.,
Cremers F.P.M.,
Kremer H.;
"A mutation in the gamma actin 1 (ACTG1) gene causes autosomal dominant hearing loss (DFNA20/26).";
J. Med. Genet. 40:879-884(2003).
|
[15]
|
VARIANT DFNA20 ALA-370, AND CHARACTERIZATION OF VARIANT DFNA20 ALA-370.
DOI=10.1038/sj.ejhg.5201670; PubMed=16773128 [NCBI, ExPASy, EBI, Israel, Japan]
Rendtorff N.D.,
Zhu M.,
Fagerheim T.,
Antal T.L.,
Jones M.,
Teslovich T.M.,
Gillanders E.M.,
Barmada M.,
Teig E.,
Trent J.M.,
Friderici K.H.,
Stephan D.A.,
Tranebjaerg L.;
"A novel missense mutation in ACTG1 causes dominant deafness in a Norwegian DFNA20/26 family, but ACTG1 mutations are not frequent among families with hereditary hearing impairment.";
Eur. J. Hum. Genet. 14:1097-1105(2006).
|
|
ExPASy Home page
SIB Switzerland
